NDI
NPA Supports Lawful Marketing of Vinpocetine
The Natural Products Association (NPA) has submitted comments to the U.S. Food and Drug Administration (FDA) in response to the agency’s recent actions to ban vinpocetine. FDA is collecting public comments following a Federal Register notice that would effectively ban vinpocetine, a widely used product found in safe and legal dietary supplements. The FDA’s decision ...
FDA Considering Vinpocetine Ineligible as a Dietary Ingredient
The U.S. Food and Drug Administration (FDA) recently released an unprecedented Federal Register (FR) notice (Docket No: FDA-2016-N-2523) with major implications for acknowledged new dietary ingredient (NDI) notifications. FDA appears to be attempting to shift the burden of demonstrating reasonable expectation of safety for vinpocetine on the industry by using the hook that it can’t ...
Defending DSHEA
The Dietary Supplements Health and Education Act of 1994 (DSHEA) amended previous statutes to encompass dietary supplement-specific provisions including the definition of a “dietary supplement,” product safety, nutritional statements and claims, ingredient and nutritional labeling, good manufacturing procedures and the classification of “new” dietary ingredients. While giving manufacturers the ability to use select, approved claims, ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
